Form 6-K ASTRAZENECA PLC For: Jun 30
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260727/A5BYAG2C8Z22HZZU22Z82ZZZNTJAZ2U2Z28G
Filed on: July 27, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Imfinzi plus tarlatamab shows survival gains in lung cancer trial
- China's Latest AI Model Brings General-Purpose Agentic Capability to Edge Devices at a Lower Cost
- AstraZeneca COPD drug tozorakimab cuts exacerbations in Phase III trials
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
